BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25596466)

  • 21. Relation of Cardiac Dysfunction to Rhythm Abnormalities in Patients With Duchenne or Becker Muscular Dystrophies.
    Chiang DY; Allen HD; Kim JJ; Valdes SO; Wang Y; Pignatelli RH; Lotze TE; Miyake CY
    Am J Cardiol; 2016 Apr; 117(8):1349-54. PubMed ID: 26952271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac management in neuromuscular diseases.
    Allen HD; Thrush PT; Hoffman TM; Flanigan KM; Mendell JR
    Phys Med Rehabil Clin N Am; 2012 Nov; 23(4):855-68. PubMed ID: 23137741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decomposition-based quantitative electromyography in the evaluation of muscular dystrophy severity.
    Derry KL; Venance SL; Doherty TJ
    Muscle Nerve; 2012 Apr; 45(4):507-13. PubMed ID: 22431083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the North Star Ambulatory Assessment scale and cardiac abnormalities in ambulant boys with Duchenne muscular dystrophy.
    Ergul Y; Ekici B; Nisli K; Tatli B; Binboga F; Acar G; Ozmen M; Omeroglu RE
    J Paediatr Child Health; 2012 Jul; 48(7):610-6. PubMed ID: 22404693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular magnetic resonance reveals similar damage to the heart of patients with Becker and limb-girdle muscular dystrophy but no cardiac symptoms.
    Yilmaz A; Gdynia HJ; Mahrholdt H; Sechtem U
    J Magn Reson Imaging; 2009 Oct; 30(4):876-7. PubMed ID: 19787739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril.
    Mavrogeni S; Giannakopoulou A; Papavasiliou A; Markousis-Mavrogenis G; Pons R; Karanasios E; Noutsias M; Kolovou G; Papadopoulos G
    BMC Cardiovasc Disord; 2017 Jul; 17(1):197. PubMed ID: 28738778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
    Jefferies JL; Eidem BW; Belmont JW; Craigen WJ; Ware SM; Fernbach SD; Neish SR; Smith EO; Towbin JA
    Circulation; 2005 Nov; 112(18):2799-804. PubMed ID: 16246949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LAMA2-related myopathy: Frequency among congenital and limb-girdle muscular dystrophies.
    Løkken N; Born AP; Duno M; Vissing J
    Muscle Nerve; 2015 Oct; 52(4):547-53. PubMed ID: 25663498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary Bone Defect in Neuromuscular Diseases in Childhood: A Longitudinal "Muscle-Bone Unit" Analysis.
    Ribstein C; Courteix D; Rabiau N; Bommelaer C; Bourdeau Y; Pereira B; Sarret C
    Neuropediatrics; 2018 Dec; 49(6):397-400. PubMed ID: 29980148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac involvement in limb-girdle muscular dystrophy 2I : conventional cardiac diagnostic and cardiovascular magnetic resonance.
    Gaul C; Deschauer M; Tempelmann C; Vielhaber S; Klein HU; Heinze HJ; Zierz S; Grothues F
    J Neurol; 2006 Oct; 253(10):1317-22. PubMed ID: 16786213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The heart in Becker muscular dystrophy, facioscapulohumeral dystrophy, and Bethlem myopathy.
    de Visser M; de Voogt WG; la Rivière GV
    Muscle Nerve; 1992 May; 15(5):591-6. PubMed ID: 1584251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum cardiac troponin I is a candidate biomarker for cardiomyopathy in Duchenne and Becker muscular dystrophies.
    Yamaguchi H; Awano H; Yamamoto T; Nambu Y; Iijima K
    Muscle Nerve; 2022 May; 65(5):521-530. PubMed ID: 35174514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronologic study of signs of myocardiopathy in progressive muscular dystrophy].
    Barona Zamora P; Narbona García J; Alvarez Gómez MJ; Fidalgo Andrés ML; Sáenz de Buruaga J; Villa Elizaga I
    An Esp Pediatr; 1993 Feb; 38(2):173-7. PubMed ID: 8439105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclinical cardiomyopathy in Becker muscular dystrophy.
    Steare SE; Dubowitz V; Benatar A
    Br Heart J; 1992 Sep; 68(3):304-8. PubMed ID: 1389764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of cardiac involvement in different muscular dystrophies assessed by magnetic resonance imaging.
    Goebel J; Schult K; Schara U; Neudorf U; Forsting M; Schlosser T; Nassenstein K
    Acta Radiol; 2023 Feb; 64(2):605-611. PubMed ID: 35147046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac Intervention Improves Heart Disease and Clinical Outcomes in Patients With Muscular Dystrophy in a Multidisciplinary Care Setting.
    Nikhanj A; Yogasundaram H; Miskew Nichols B; Richman-Eisenstat J; Phan C; Bakal JA; Siddiqi ZA; Oudit GY
    J Am Heart Assoc; 2020 Jan; 9(2):e014004. PubMed ID: 31931688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The proteoglycan-dystrophin complex in genetic cardiomyopathies--lessons from three siblings with limb-girdle muscular dystrophy-2I (LGMD-2I).
    Yilmaz A; Gdynia HJ; Ponfick M; Ludolph AC; Rösch S; Sechtem U
    Clin Res Cardiol; 2011 Jul; 100(7):611-5. PubMed ID: 21311896
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies.
    Hussein MR; Hamed SA; Mostafa MG; Abu-Dief EE; Kamel NF; Kandil MR
    Int J Exp Pathol; 2006 Dec; 87(6):451-61. PubMed ID: 17222213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Creatine kinase response to high-intensity aerobic exercise in adult-onset muscular dystrophy.
    Andersen SP; Sveen ML; Hansen RS; Madsen KL; Hansen JB; Madsen M; Vissing J
    Muscle Nerve; 2013 Dec; 48(6):897-901. PubMed ID: 23512655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac treatment in neuro-muscular diseases.
    Nigro G; Politano L; Passamano L; Palladino A; De Luca F; Nigro G; Comi LI
    Acta Myol; 2006 Dec; 25(3):119-23. PubMed ID: 17626520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.